Tensegrity Law Group

Firm overview:

Since its launch in 2011 by former Weil Gotshal & Manges partners and associates, Tensegrity Law Group is as a focused, trial-driven patent litigation boutique. In 2025, the firm remained highly active across all stages of patent disputes, from pre-suit strategy and enforcement through to jury trials, bench trials and arbitrations in key patent venues across the US.

The firm’s strength is in patent enforcement and monetisation matters, where it regularly represents patent owners in muliti-million dollar disputes involving sophisticated technologies. Such as the jury trial victory the firm presented 10x Genomics and Prognosys with lost profits awarded due to infringement. Its trial team is frequently praised for its ability to present technically complex cases in a compelling manner, and for maintaining an impressive record of success before juries, judges and arbitration panels.

Alongside contentious work, Tensegrity continues to provide patent portfolio assessment and mining services. Offered on a fixed-fee basis, these services are often deployed as a strategic precursor to litigation, enabling clients to evaluate the strength, scope and commercial potential of their patent assets before pursuing enforcement or monetisation strategies. This integrated approach has remained a key draw for clients in 2025 seeking cost-certainty and trial-ready insight.

Team overview:

Founding partner Matthew Powers remains the firm’s central figure and is known in the patent litigation market. Renowned for winning difficult cases, Powers has tried patent matters in every major US patent venue and continues to lead complex disputes involving patents, trade secrets, fraud and fiduciary duty. His career includes leading trial teams to billion-dollar verdicts and settlements for some of the world’s leading companies, and he remains highly sought after for matters where trial credibility is paramount.

Fellow founding partner Paul Ehrlich is another cornerstone of the practice and continues to act as trial counsel in matters involving billions of dollars in dispute. He brings deep experience in patent litigation before US district courts and the International Trade Commission, and is valued for his ability to master highly technical subject matter across a wide range of industries. His expertise spans mobile devices, consumer electronics, medical devices and biotechnology, making him a versatile and effective advocate in complex, technology-driven cases.

Key matters:

• 10X Genomics, Inc Petitioner, v Nanostring Technologies Inc, Patent Owner, Patent Owner, (2024)

The Firm presented the case for 10X before the PTAB against Nanostring Technologies. The firm filed for an inter partes review challenging the claims of an existing patent involving spatial biology and molecular imaging technology.

The proceedings were terminated on May 21, 2025, following a joint motion after a global settlement between Bruker (which acquired NanoString) and 10x Genomics.

Key members on the Tensegrity team included Matthew Powers, Paul Ehrlich, Robert L. Gerrity and Kiley A. White.

Clients:

10x Genomics, Arista Networks, Memory Technologies, Skyhook Wireless, Wake Forest University Health Sciences